Considering that dysregulated IL-6 activity is associated with chronic inflammation and atherosclerosis, and that circulating IL-6 is an independent predictor of carotid plaque severity, vulnerability, and progression20, our findings suggest that, by increasing IL-6 expression by SMC, ficolin-2 may contribute to the acceleration of plaque progression towards vulnerability. Here, FCN2 is linked to atherosclerosis.